4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Entera Bio Ltd. (ENTX) operates in the Biotechnology industry and is headquartered in Jerusalem, Israel with about 20 employees. Its market capitalization is roughly $85 million. In the fiscal year ended 2025-12-31, ENTX reported $0M in revenue and ($11M) in net income.
Entera Bio Ltd., a clinical stage company, engages in the development of oral peptides and protein replacement therapies in Israel and internationally.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Gross Profit | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($12M) | ($10M) | ($9M) | ($13M) | — |
| Net Income | ($11M) | ($10M) | ($9M) | ($13M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Gross Profit | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($4M) | ($3M) | ($3M) | ($3M) | ($3M) | — |
| Net Income | ($4M) | ($3M) | ($3M) | ($3M) | ($3M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $16M | $9M | $12M | $13M | — |
| Total Liabilities | $3M | $1M | $1M | $1M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ENTX viewer.
About TickerBase · Data methodology & sources